行情

ANIP

ANIP

阿尼制药
NASDAQ

实时行情|Nasdaq Last Sale

30.37
+0.87
+2.95%
盘后: 30.37 0 0.00% 16:45 08/07 EDT
开盘
29.22
昨收
29.50
最高
30.60
最低
29.04
成交量
7.34万
成交额
--
52周最高
80.87
52周最低
25.23
市值
3.75亿
市盈率(TTM)
-210.9028
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ANIP价格均价为39.33,最高价位48.00,最低价为30.00。

EPS

ANIP 新闻

更多
ANI Pharmaceuticals (ANIP) Q2 Earnings Miss Estimates
ANI (ANIP) delivered earnings and revenue surprises of -2.82% and 6.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 2天前
ANI Pharmaceuticals Reports Second Quarter 2020 Results
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced business highlights and financial results for the three and six months ended June 30, 2020.
Business Wire · 2天前
ANI Pharmaceuticals Appoints Experienced Pharmaceutical Executives, Jeanne Thoma and Antonio "Tony" Pera to Board of Directors
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Officer of SPI Pharma, Inc. and Antonio ("Tony") Pera, former President of Par Pharmaceutical to the ANI Pharmaceut
Business Wire · 2天前
New chief at ANI Pharmaceuticals
Effective September 8, ANI Pharmaceuticals (NASDAQ:ANIP) appoints Nikhil Lalwani as President and CEO succeeding Patrick D. Walsh Mr. Walsh to continue as
seekingalpha · 5天前
Raymond James Maintains Outperform on ANI Pharmaceuticals, Lowers Price Target to $40
Raymond James maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Outperform and lowers the price target from $49 to $40.
Benzinga · 5天前
ANI Pharmaceuticals Names Nikhil Lalwani As President And Chief Executive Officer
Benzinga · 5天前
ANI Pharmaceuticals Names Nikhil Lalwani as President and Chief Executive Officer
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that Nikhil Lalwani has been named the Company’s President and Chief Executive Officer, effective September 8, 2020. Mr. Lalwani will also be elected to the Company’s Board of Di
Business Wire · 5天前
ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter 2020 Financial Results
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ: ANIP) today announced that the Company will release its second quarter 2020 financial results on Thursday, August 6, 2020, before the opening of the U.S. financial markets.
Business Wire · 07/30 10:50

所属板块

生物技术和医学研究
-0.18%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

ANIP 简况

ANI Pharmaceuticals, Inc.是一家综合性专业制药公司。该公司从事开发、制造和销售品牌和通用处方药。该公司的主要开发领域包括抗癌(溶瘤)、激素和类固醇,以及复合配方。其通用产品包括甲基睾酮酯化雌激素、依托度酸、氟卡胺、三氟戊肟胺、氢化可的松灌肠剂、甲醋唑胺、尼莫地平、鸦片酊、氧可酮口服液、丙胺苯丙酮和万古霉素。其品牌产品包括氢化可的松、碳酸锂、胃复安和万古霉素。它在明尼苏达州鲍德特拥有两家制药厂,生产口服固体剂量产品,以及液体和局部、受控物质和有效产品。它有两个联合制造、包装和实验室用途的工厂,面积达17.3万平方英尺。
展开

微牛提供ANI Pharmaceuticals Inc(NASDAQ-ANIP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ANIP股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ANIP股票基本功能。